Pfizer says Viagra holding strong

Viagra is the main treatment for Romanians with erectile dysfunction, with other treatments including testosterone, Masculan, Top On, Cialis and Levitra. These are the findings of a Mercury Research survey commissioned by the US Pfizer Group, owner of the Viagra brand. Out of the total respondents that admitted they were treated for erectile dysfunction, 56% said they were using Viagra, 22% testosterone, 8% Masculan, 6% Top On, 5% Cialis and 2% Levitra. The Mercury Research survey was published on Monday, two weeks after US Eli Lilly Group announced that Cialis had seen some $500,000 in sales between April 2003-April 2004, its first year on the Romanian market. Sales of Viagra are estimated as standing at $1.7-$1.8 million in 2003. The survey was conducted about a year after the first conventional competitor to Viagra (Eli Lilly’s Cialis) was introduced onto a Romanian market worth around $ 2 million. ZF